tradingkey.logo

Bionano Genomics Inc

BNGO
查看詳細走勢圖
1.600USD
+0.010+0.63%
收盤 12/19, 16:00美東報價延遲15分鐘
15.57M總市值
虧損本益比TTM

Bionano Genomics Inc

1.600
+0.010+0.63%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.63%

5天

-1.23%

1月

+7.38%

6月

-50.00%

今年開始到現在

-90.75%

1年

-86.32%

查看詳細走勢圖

TradingKey Bionano Genomics Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Bionano Genomics Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名148/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價7.50。中期看,股價處於平穩狀態。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bionano Genomics Inc評分

相關信息

行業排名
148 / 208
全市場排名
396 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 3 分析師
買入
評級
7.500
目標均價
+357.32%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bionano Genomics Inc亮點

亮點風險
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
業績增長期
公司處於發展階段,最新年度總收入30.78M美元
估值高估
公司最新PE估值-0.00,處於3年歷史高位
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉0.00股

Bionano Genomics Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bionano Genomics Inc簡介

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
公司代碼BNGO
公司Bionano Genomics Inc
CEOHolmlin (R. Erik)
網址https://bionano.com/

常見問題

Bionano Genomics Inc(BNGO)的當前股價是多少?

Bionano Genomics Inc(BNGO)的當前股價是 1.600。

Bionano Genomics Inc 的股票代碼是什麼?

Bionano Genomics Inc的股票代碼是BNGO。

Bionano Genomics Inc股票的52週最高點是多少?

Bionano Genomics Inc股票的52週最高點是22.800。

Bionano Genomics Inc股票的52週最低點是多少?

Bionano Genomics Inc股票的52週最低點是1.450。

Bionano Genomics Inc的市值是多少?

Bionano Genomics Inc的市值是15.57M。

Bionano Genomics Inc的淨利潤是多少?

Bionano Genomics Inc的淨利潤為-112.02M。

現在Bionano Genomics Inc(BNGO)的股票是買入、持有還是賣出?

根據分析師評級,Bionano Genomics Inc(BNGO)的總體評級為買入,目標價格為7.500。

Bionano Genomics Inc(BNGO)股票的每股收益(EPS TTM)是多少

Bionano Genomics Inc(BNGO)股票的每股收益(EPS TTM)是-5212.601。
KeyAI